Patent ductus arteriosus: how important to which babies?

Early Human Development

Volumn 29, Issue 1-3, 1992, Pages 287-292

  Knight, D B ^a  

^a NATIONAL WOMEN S HOSPITAL   (New Zealand)

Author keywords

blood pressure; chronic lung disease; overview; patent ductus arteriosus; premature infant

Indexed keywords

INDOMETACIN;

BLOOD PRESSURE; CHRONIC LUNG DISEASE; CONFERENCE PAPER; DUCTUS ARTERIOSUS; INFANT MORTALITY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; VERY LOW BIRTH WEIGHT;

DUCTUS ARTERIOSUS, PATENT; HUMAN; HYPOTENSION; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS;

EID: 0026771029     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-3782(92)90179-K     Document Type: Article

References (22)

1. Secondary prevention of vascular disease by prolonged antiplatelet treatment
2. Randomised trial of early closure of symptomatic patent ductus arteriosus in small preterm infants
3. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study
4. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus — a double-blind controlled study
5. Indomethacin for closure of patent ductus arteriosus in prematures
6. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study
7. Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: a double blind trial
8. Early closure of the patent ductus arteriosus in very low-birth-weight infants: a controlled trial
9. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants
10. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome
11. Failure of prophylactic indomethacin to improve the outcome of the very low birth weight infant
12. Auswirkungeneiner Frnhtherapie mit Indomethacin auf die Manifestation eines persistlerenden Ductus arteriosus bei extrem untergewichtigen Fruhgeborenen
13. Indomethacin therapy on the first day of life in infants with very low birth weight
14. Randomised indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants
15. Early administration of indomethacin to preterm infants
16. Early intravenous indomethacin prolongs respiratory support in very low birth weight infants
17. Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin
18. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants
19. Administration of indomethacin for the prevention of periventricular-intraventricular hemorrhage in high-risk neonates
20. Randomised low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates
21. Indomethacin reduces the risk of severe intraventricular hemorrhage
22. A randomised controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth